Objective To evaluate the effect of
clinical pharmacists participating in the
treatment of hospitalized
patients with
diabetic foot by
antibiotics management index and
health economics index.
Methods 40 hospitalized
patients with
diabetic foot of Wagner Grade 4 in the Endocrine Department of
Air Force Medical Center from April to September 2017 were selected as
control group, and 40 hospitalized
patients with
diabetic foot of Wagner Grade 4 in the Endocrine Department from April to September 2019 were selected as interventional group. No
clinical pharmacists were involved in
drug treatment of
patients in the
control group, while the
clinical pharmacists in the interventional group participated in
drug treatment, and implemented
antimicrobial stewardship,
medication reconciliation,
pharmaceutical care and medication
education.
Antibiotics management indexes (use intensity of
antibiotics, use rate of special class
antibiotics) and
health economics indexes (
medicine expenses,
hospitalization expenses) of the two groups were compared. Results The
efficacy of the two groups was
similar. The use intensity of
antibiotics and use rate of special class
antibiotics of the interventional group in which
clinical pharmacists participated were significantly lower than the
control group (P<0.01), so were the
medicine expenses and
hospitalization expenses (P<0.01). Conclusion
Clinical pharmacists participating in the
treatment of hospitalized
patients with
diabetic foot could reduce
antibiotics administration index and
health economics index, promote rational
medicine use and save medical expenses.